Successful long-term treatment of non–small cell lung cancer positive for RET rearrangement with pemetrexed

The discovery of RET rearrangement in non–small cell lung cancer (NSCLC) has prompted development of molecularly targeted therapy for such tumors, with several clinical trials being under way to evaluate the therapeutic effects of multitargeted tyrosine kinase inhibitors. The sensitivity of RET fusi...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Masayuki, Sakai, Kazuko, Nishio, Kazuto, Nakagawa, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625745/
https://www.ncbi.nlm.nih.gov/pubmed/31360064
http://dx.doi.org/10.2147/OTT.S211582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625745/
https://www.ncbi.nlm.nih.gov/pubmed/31360064
http://dx.doi.org/10.2147/OTT.S211582

Ejemplares similares